These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26293390)

  • 21. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe lung disease in children with cystic fibrosis missed in newborn screening.
    Baldwin K; Barker EM; Carayannopoulos M; Farrell PM; Zanni R; Scanlin TF
    Pediatr Pulmonol; 2024 Jan; 59(1):163-168. PubMed ID: 37888495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
    McGarry ME; Sciortino S; Graham S; Bishop T; Gibb ER
    Pediatr Pulmonol; 2024 Nov; 59(11):2901-2909. PubMed ID: 38940324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.
    Gregg RG; Simantel A; Farrell PM; Koscik R; Kosorok MR; Laxova A; Laessig R; Hoffman G; Hassemer D; Mischler EH; Splaingard M
    Pediatrics; 1997 Jun; 99(6):819-24. PubMed ID: 9164776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.
    Gregg RG; Wilfond BS; Farrell PM; Laxova A; Hassemer D; Mischler EH
    Am J Hum Genet; 1993 Mar; 52(3):616-26. PubMed ID: 7680526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False negatives in the newborn screening for cystic fibrosis in Western Andalusia: Results from a 10-year experience.
    Escudero-Ávila R; Delgado-Pecellín C; Moreno-Valera MJ; Carrasco-Hernández L; Quintana-Gallego ME; Delgado-Pecellín I
    Pediatr Pulmonol; 2023 Sep; 58(9):2464-2468. PubMed ID: 36196044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
    Sontag MK; Wright D; Beebe J; Accurso FJ; Sagel SD
    J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in cystic fibrosis newborn screening algorithms in the United States.
    Rehani MR; Marcus MS; Harris AB; Farrell PM; Ren CL
    Pediatr Pulmonol; 2023 Mar; 58(3):927-933. PubMed ID: 36507555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium.
    Schmidt M; Werbrouck A; Verhaeghe N; De Wachter E; Simoens S; Annemans L; Putman K
    Acta Clin Belg; 2020 Jun; 75(3):212-220. PubMed ID: 31007159
    [No Abstract]   [Full Text] [Related]  

  • 32. Why cystic fibrosis newborn screening programs have failed to meet original expectations… thus far.
    Farrell PM
    Mol Genet Metab; 2023; 140(1-2):107679. PubMed ID: 37573205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.
    Lundman E; Gaup HJ; Bakkeheim E; Olafsdottir EJ; Rootwelt T; Storrøsten OT; Pettersen RD
    J Cyst Fibros; 2016 May; 15(3):318-24. PubMed ID: 26795017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
    Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
    Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations.
    Sommerburg O; Krulisova V; Hammermann J; Lindner M; Stahl M; Muckenthaler M; Kohlmueller D; Happich M; Kulozik AE; Votava F; Balascakova M; Skalicka V; Stopsack M; Gahr M; Macek M; Mall MA; Hoffmann GF
    J Cyst Fibros; 2014 Jan; 13(1):15-23. PubMed ID: 23891278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial regional evaluation of the Cystic Fibrosis Newborn Screening Program: data from the Mediterranean coast of Turkey.
    Başaran AE; Başaran A; Kocacik DF; Alper Ö; Acican D; Bingöl A
    Turk J Med Sci; 2019 Dec; 49(6):1655-1661. PubMed ID: 31655510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers.
    Castellani C; Picci L; Scarpa M; Dechecchi MC; Zanolla L; Assael BM; Zacchello F
    Am J Med Genet A; 2005 Jun; 135(2):142-4. PubMed ID: 15832355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study for cystic fibrosis neonatal screening: the Cuban experience.
    Castells EM; Sánchez A; Frómeta A; Mokdse Y; Ozunas N; Licourt T; Arteaga AL; Silva E; Collazo T; Rodríguez F; Martín O; Espinosa M; Del Río L; Pérez PL; Morejón G; Almira C; Núñez Z; Melchor A; González EC
    Clin Chem Lab Med; 2020 Oct; 58(11):1857-1864. PubMed ID: 32352395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy.
    Audrézet MP; Munck A; Scotet V; Claustres M; Roussey M; Delmas D; Férec C; Desgeorges M
    Genet Med; 2015 Feb; 17(2):108-16. PubMed ID: 25122143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.
    Hale JE; Parad RB; Dorkin HL; Gerstle R; Lapey A; O'Sullivan BP; Spencer T; Yee W; Comeau AM
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S255-61. PubMed ID: 20521170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.